EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment and secondary prophylaxis of VTE in the cancer patient: current status



Treatment and secondary prophylaxis of VTE in the cancer patient: current status



Pathophysiology of Haemostasis and Thrombosis 33 Suppl 1: 42-43




(PDF same-day service: $19.90)

Accession: 035980051

Download citation: RISBibTeXText

PMID: 12955000

DOI: 73289



Related references

Current perspectives on primary prophylaxis and patient risk factors for venous thromboembolism in the cancer patient. Cancer Control 12 Suppl 1: 11-16, 2005

Some current aspects of the course treatment and secondary prophylaxis of peptic ulcers. Klinicheskaya Meditsina (Moscow) 68(4): 134-142, 1990

The current status of malaria prophylaxis and treatment. Bulletin de la Societe de Pathologie Exotique 74(6): 595-599, 1981

Current Status of CD4-Based Therapies for Prophylaxis and Treatment of HIV Infection. Biodrugs 8(2): 128-138, 1997

The 42nd Scientific Meeting: Perspectives of Internal Medicine; Considerations to treatment and care of cancer by internists in the era of increasing cancer mortality; 3. Current Status of Diagnosis and Treatment of Cancer; 3) Cancer biomarker and individualized therapy. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 104(3): 449-455, 2016

The 42nd Scientific Meeting: Perspectives of Internal Medicine; Considerations to treatment and care of cancer by internists in the era of increasing cancer mortality; 3. Current Status of Diagnosis and Treatment of Cancer; 1) Recent diagnostic imaging for cancer. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 104(3): 436-442, 2016

Current status of the surgical treatment of secondary hyperparathyroidism. Minerva Chirurgica 40(4): 229-233, 1985

Failure of conventional treatment with pyrimethamine and sulfadiazine for secondary prophylaxis of cerebral toxoplasmosis in a patient with AIDS. Journal of Antimicrobial ChemoTherapy 66(7): 1654-1656, 2011

Liposomal Amphotericin B for treatment of acute phase and secondary prophylaxis of visceral leishmaniasis in a HIV positive patient. Le Infezioni in Medicina 8(4): 241-244, 2003

Primary and secondary prevention of cancer in children and adolescents: current status and issues. Pediatric Clinics of North America 33(4): 975-993, 1986

Current status evaluation of dietary fat reduction as secondary breast cancer prevention. Engstrom, P F , B Rimer And L E Mortenson (Ed ) Progress in Clinical And Biological Research, Vol 339 Advances in Cancer Control: Screening And Prevention Research; Association Of Community Cancer Centers 15th National Meeting, Bethesda, Maryland, Usa, March 29-April 1, 1989 Xxi+495p Wiley-Liss: New York, New York, Usa; Chichester, England, Uk Illus 201-210, 1990

Current status of the treatment of cancer of the cervix uteri. Current surgical methods. Prensa Medica Argentina 57(29): 1435-1438, 1970

General examination and treatment of patient in recurrent calcium nephrolithiasis of metabolic origin secondary prophylaxis methodological survey. Orvoskepzes 63(3): 183-193, 1988

Targeted tailored management of the breast cancer patient at risk for harboring a germline mutation-current trends affecting the selection of patients considering surgical prophylaxis for breast cancer. Breast Journal 15 Suppl 1: S76-S80, 2009

The role of oxidative stress in diseases caused by mineral dusts and fibres: Current status and future of prophylaxis and treatment. Molecular & Cellular Biochemistry 196(1-2): 69-77, June, 1999